Plasma Levels of Pentosidine, Carboxymethyl-Lysine, Soluble Receptor for Advanced Glycation End Products, and Metabolic Syndrome: The Metformin Effect

Table 5

Correlation between pentosidine, sRAGE, and drugs treatments in patients with MetS: multivariate regression analysis.

Variables	Pentosidine		sRAGE
	Metformin treatment	−0.246	0.099	0.045	0.73
ACE inhibitors treatment	−0.299	0.182	0.08	0.685
Metformin + ACE inhibitors treatment	−0.236	0.951	0.326	0.143

ANOVA revealed a statistically not significant fit ().
A stepwise multivariate regression was performed.